Ikenko Health Tech Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.20 M
as on 13-12-2024
- Company Age 5 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit -74.19%
(FY 2022)
- Ebitda -150.62%
(FY 2022)
- Net Worth 557.39%
(FY 2022)
- Total Assets 657.69%
(FY 2022)
About Ikenko Health Tech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Dhiraj Goel and Aniruddha Sen serve as directors at the Company.
- CIN/LLPIN
U72900MH2019PTC326102
- Company No.
326102
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 May 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ikenko Health Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhiraj Goel  | Director | 05-Jul-2023 | Current |
| Aniruddha Sen | Director | 30-May-2019 | Current |
Financial Performance of Ikenko Health Tech.
Ikenko Health Tech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 74.19% decrease in profit. The company's net worth Soared by an impressive increase of 557.39%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ikenko Health Tech?
In 2021, Ikenko Health Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Redkenko Health Tech Private LimitedActive 4 years 11 monthsDhiraj Goel and Aniruddha Sen are mutual person
- Kenko General Insurance LimitedActive 2 years 7 months
Dhiraj Goel and Aniruddha Sen are mutual person
- Rikenko Technology Health Tech Private LimitedActive 3 years 3 months
Dhiraj Goel and Aniruddha Sen are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ikenko Health Tech?
Ikenko Health Tech has a workforce of 57 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ikenko Health Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikenko Health Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
